Nutritional status and incidence of hepatocellular carcinoma in patients with compensated liver cirrhosis

被引:0
作者
Lopez-Sanchez, Marlene [1 ]
Bautista-Santos, Aleida [2 ]
Milke-Garcia, Maria del Pilar [3 ]
Allende-Lopez, Aldo [1 ]
Moreno-Alcantar, Rosalba [2 ]
Moran, Segundo [1 ]
机构
[1] Ctr Med Nacl Siglo XXI, Inst Mexicano Seguro Social, Lab Hepatol Res, Mexico City, Mexico
[2] Ctr Med Nacl Siglo XXI, Gastroenterol Serv, Inst Mexicano Seguro Social, Mexico City, Mexico
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Hematooncol Dept, Mexico City, Mexico
关键词
Hepatocellular carcinoma; Nutritional assessment; Compensated liver cirrhosis; NATURAL-HISTORY; HEPATITIS-C; RISK-FACTORS; MALNUTRITION; AMINOTRANSFERASE; PROGRESSION; MORTALITY; ALPHA;
D O I
10.1016/j.arcmed.2024.103127
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Malnutrition in patients with liver cirrhosis (LC) and/or hepatocellular carcinoma (HCC) has been associated with adverse outcomes. However, there is little information on the incidence of HCC during the compensated phase of LC in relation to the nutritional status. Aim. To evaluate the association between the incidence of HCC in compensated LC and their nutritional status. Methods. Patients with compensated liver cirrhosis with no previous history of ascites, hepatic encephalopathy, or variceal bleeding attending the Gastroenterology outpatient service at Centro Medico Nacional Siglo XXI were included in a prospective cohort. Clinical and nutritional parameters were collected, including the Royal Free Hospital Subjective Global Assessment (RFH-SGA) as an indicator of protein-calorie malnutrition and the triceps skinfold thickness, which classified patients as having normal subcutaneous adipose tissue (SAT), above average SAT, and below average SAT. Follow-up was censored at the time of HCC diagnosis or LC decompensation. Results. About 31/187 (16.0 %) and 22/187 (11.8 %) patients were categorized as having above- or below-average SAT at baseline, respectively. 10/187 patients (5.3 %) developed HCC during the compensated phase of LC at a median of 22 months (IQR: 10.0-36.75). A higher risk of HCC was observed in subjects below average SAT (HR: 4.064, CI 95 %: 1.012-16.317, p = 0.048). After adjusting the Cox models for age and alpha-fetoprotein at baseline, the statistical significance of the association between SAT and HCC was not modified. Conclusion. These results suggest that decreased SAT may precede the diagnosis of HCC by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:14
相关论文
共 47 条
[11]   Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis [J].
Ha, Nghiem B. ;
Cho, Soo-Jin ;
Mohamad, Yara ;
Kent, Dorothea ;
Jun, Grace ;
Wong, Randi ;
Swarnakar, Vivek ;
Lin, Shezhang ;
Maher, Jacquelyn J. ;
Lai, Jennifer C. .
DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (07) :3436-3444
[12]   Oral Branched-Chain Amino Acid Granules Reduce the Incidence of Hepatocellular Carcinoma and Improve Event-Free Survival in Patients with Liver Cirrhosis [J].
Hayaishi, Sosuke ;
Chung, Hobyung ;
Kudo, Masatoshi ;
Ishikawa, Emi ;
Takita, Masahiro ;
Ueda, Taisuke ;
Kitai, Satoshi ;
Inoue, Tatsuo ;
Yada, Norihisa ;
Hagiwara, Satoru ;
Minami, Yasunori ;
Ueshima, Kazuomi .
DIGESTIVE DISEASES, 2011, 29 (03) :326-332
[13]   Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naive patients with chronic hepatitis B-related compensated cirrhosis in Taiwan [J].
Hu, Tsung-Hui ;
Chiu, Sherry Yueh-Hsia ;
Tseng, Po-Lin ;
Chen, Chien-Hung ;
Lu, Sheng-Nan ;
Wang, Jing-Houng ;
Hung, Chao-Hung ;
Kee, Kwong-Ming ;
Lin, Ming-Tsung ;
Chang, Kuo-Chin ;
Lin, Meng-Chih ;
Chien, Rong-Nan .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (11-12) :1695-1706
[14]   Protein energy malnutrition predicts complications in liver cirrhosis [J].
Huisman, Ellen J. ;
Trip, Evelien J. ;
Siersema, Peter D. ;
van Hoek, Bart ;
van Erpecum, Karel J. .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (11) :982-989
[15]   Lenvatinib or Sorafenib Treatment Causing a Decrease in Skeletal Muscle Mass, an Independent Prognostic Factor in Hepatocellular Carcinoma: A Survival Analysis Using Time-Varying Covariates [J].
Imai, Kenji ;
Takai, Koji ;
Unome, Shinji ;
Miwa, Takao ;
Hanai, Tatsunori ;
Suetsugu, Atsushi ;
Shimizu, Masahito .
CANCERS, 2023, 15 (17)
[16]   Rapid Depletion of Subcutaneous Adipose Tissue during Sorafenib Treatment Predicts Poor Survival in Patients with Hepatocellular Carcinoma [J].
Imai, Kenji ;
Takai, Koji ;
Miwa, Takao ;
Taguchi, Daisuke ;
Hanai, Tatsunori ;
Suetsugu, Atsushi ;
Shiraki, Makoto ;
Shimizu, Masahito .
CANCERS, 2020, 12 (07) :1-10
[17]   Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib [J].
Imai, Kenji ;
Takai, Koji ;
Miwa, Takao ;
Taguchi, Daisuke ;
Hanai, Tatsunori ;
Suetsugu, Atsushi ;
Shiraki, Makoto ;
Shimizu, Masahito .
CANCERS, 2019, 11 (08)
[18]  
Imai Kenji, 2018, Oncotarget, V9, P14058, DOI 10.18632/oncotarget.24500
[19]   Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis [J].
Kim, Ji Hyun ;
Lee, Minjong ;
Park, Seung Woo ;
Kang, Myungho ;
Kim, Minjeong ;
Lee, Sang Hoon ;
Kim, Tae Suk ;
Park, Jin Myung ;
Choi, Dae Hee .
MEDICINE, 2018, 97 (48)
[20]   Natural history of compensated cirrhosis in the Child-Pugh Class A compared between 490 patients with hepatitis C and 167 with B virus infections [J].
Kobayashi, M ;
Ikeda, K ;
Hosaka, T ;
Sezaki, H ;
Someya, T ;
Akuta, N ;
Suzuki, F ;
Suzuki, Y ;
Saitoh, S ;
Arase, Y ;
Miyakawa, Y ;
Kumada, H .
JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (04) :459-465